Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancer Journal Article
| Author: | Hudis, C. A. |
| Article Title: | Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancer |
| Keywords: | immunohistochemistry; survival; cancer survival; survival rate; clinical trial; cancer recurrence; doxorubicin; paclitaxel; cancer adjuvant therapy; chemotherapy; lymph node dissection; sentinel lymph node biopsy; carboplatin; breast cancer; gene amplification; mastectomy; epidermal growth factor receptor 2; cyclophosphamide; cancer mortality; docetaxel; axillary lymph node; survival time; fluorescence in situ hybridization; heart death; cardiotoxicity; short survey; trastuzumab; breast adenocarcinoma; congestive heart failure; her2; hazard assessment |
| Journal Title: | Nature Clinical Practice Oncology |
| Volume: | 3 |
| Issue: | 1 |
| ISSN: | 1743-4254 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2006-01-01 |
| Start Page: | 12 |
| End Page: | 13 |
| Language: | English |
| DOI: | 10.1038/ncponc0401 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 3" - "Export Date: 4 June 2012" - "Source: Scopus" |
